<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05123560</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-PRE-2021-23</org_study_id>
    <nct_id>NCT05123560</nct_id>
  </id_info>
  <brief_title>Women's Perspective on First-trimester Preeclampsia Screening</brief_title>
  <official_title>First-trimester Preeclampsia Screening: Women's Perspectives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate women's perception on first-trimester preeclampsia&#xD;
      screening as it is performed currently in daily practice. Thus, the investigators will assess&#xD;
      the degree of satisfaction regarding the information received previously to the date of&#xD;
      screening, and on the same day the screening is performed (at the time of first-trimester&#xD;
      scan).&#xD;
&#xD;
      Women's unsderstanding regarding preeclampsia screening will be evaluated by means of an&#xD;
      anonymous online questionnaire. Anxiety and stress related to the results will also be&#xD;
      assessed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preeclampsia screening was established in Catalonia in 2018. However, little training for&#xD;
      professionals (doctors and midwifes) was performed. Women's opinion regarding screening was&#xD;
      not asked prior to its implementation, and most women no dot receive any information prior to&#xD;
      be screened.&#xD;
&#xD;
      Women's opinion on their pregnancy follow-ups is important, but this aspect is often not&#xD;
      included in clinical practice policies. Thus, the objective of the study is to evaluate&#xD;
      women's perception regarding current clinical practice in screening of preeclampsia, and&#xD;
      their degree of satisfaction.&#xD;
&#xD;
      Screening and risk-assessments during pregnancy are also a potential cause of stress for&#xD;
      women. Anxiety and stress regarding preeclampsia screening results will also be evaluated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 20, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perception on information prior to the appointment to screen</measure>
    <time_frame>11-14 weeks of pregnancy</time_frame>
    <description>Number of Participants with a high satisfaction degree with the received information prior to screening assessed by Baker's questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perception on information received the day of the screening</measure>
    <time_frame>11-14 weeks of pregnancy</time_frame>
    <description>Number of Participants with a high satisfaction degree with the received information the day of the screening assessed by Baker's questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety and stress related to the results of the preeclampsia screening</measure>
    <time_frame>11-14 weeks of pregnancy</time_frame>
    <description>Number of Participants with high anxiety and stress levels after the screening assessed by short version of the State-Trait Anxiety Inventory (STAI)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Woman's Role</condition>
  <condition>Preeclampsia</condition>
  <condition>Screening</condition>
  <arm_group>
    <arm_group_label>women attending first-trimester ultrasound</arm_group_label>
    <description>All women attending their first-trimester ultrasound and meeting the inclusion criteria will be invited to participate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anonymous online questionnaire</intervention_name>
    <description>A QR code qill be provided to access the online questionnaire</description>
    <arm_group_label>women attending first-trimester ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All pregnant women with a singleton pregnancy attending their first-trimester ultrasound&#xD;
        and undergoing preeclampsia screening&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Older that 18 years old&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  low risc of cromosomal abnormalities (&lt;1/1100)&#xD;
&#xD;
          -  normal first trimester ultrasound (no evidence of fetal malformations)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Pacients will diagnosed mental disorders (including depression and anxiaety disorder)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>this study is only for pregnant women, regardless of their gender perceived identity</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017 Aug 17;377(7):613-622. doi: 10.1056/NEJMoa1704559. Epub 2017 Jun 28.</citation>
    <PMID>28657417</PMID>
  </reference>
  <reference>
    <citation>O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina FS, de Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides KH. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2017 Jun;49(6):751-755. doi: 10.1002/uog.17399. Epub 2017 May 14. Erratum in: Ultrasound Obstet Gynecol. 2017 Dec;50(6):807.</citation>
    <PMID>28067011</PMID>
  </reference>
  <reference>
    <citation>Rolnik DL, O'Gorman N, Roberge S, Bujold E, Hyett J, Uzan S, Beaufils M, da Silva Costa F. Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation. Ultrasound Obstet Gynecol. 2017 Nov;50(5):551-556. doi: 10.1002/uog.18899.</citation>
    <PMID>28887883</PMID>
  </reference>
  <reference>
    <citation>Simeone S, Lojo C, Garcia-Esteve L, Triunfo S, Crovetto F, Arranz A, Gratacós E, Figueras F. Psychological impact of first-trimester prevention for preeclampsia on anxiety. Prenat Diagn. 2015 Jan;35(1):60-4. doi: 10.1002/pd.4485. Epub 2014 Sep 22.</citation>
    <PMID>25156501</PMID>
  </reference>
  <reference>
    <citation>Luchian B, Neagu M, Luchian L, Vladareanu R. Preeclampsia screening from the patient's perspective. J Med Life. 2016 Jul-Sep;9(3):321-323.</citation>
    <PMID>27974943</PMID>
  </reference>
  <reference>
    <citation>Jørgensen JM, Hedley PL, Gjerris M, Christiansen M. Including ethical considerations in models for first-trimester screening for pre-eclampsia. Reprod Biomed Online. 2014 May;28(5):638-43. doi: 10.1016/j.rbmo.2014.01.013. Epub 2014 Feb 7.</citation>
    <PMID>24631382</PMID>
  </reference>
  <reference>
    <citation>Jørgensen JM, Hedley PL, Gjerris M, Christiansen M. Ethical issues related to screening for preeclampsia. Bioethics. 2014 Sep;28(7):360-7. doi: 10.1111/j.1467-8519.2012.02005.x. Epub 2012 Sep 20.</citation>
    <PMID>22994561</PMID>
  </reference>
  <reference>
    <citation>Baker R. Development of a questionnaire to assess patients' satisfaction with consultations in general practice. Br J Gen Pract. 1990 Dec;40(341):487-90.</citation>
    <PMID>2282225</PMID>
  </reference>
  <reference>
    <citation>Fernández San Martín MI, Rebagliato Nadal O, de Gispert Uriach B, Roig Carrera H, Artigas Guix J, Bonay Valls B, Guix Font L, Turmo Tristán N. [Adaptation of a patient satisfaction questionnaire on medical and nursing care]. Aten Primaria. 2008 Dec;40(12):611-6. Spanish.</citation>
    <PMID>19100148</PMID>
  </reference>
  <reference>
    <citation>Buela-Casal G, Guillén-Riquelme A. Short form of the Spanish adaptation of the State-Trait Anxiety Inventory. Int J Clin Health Psychol. 2017 Sep-Dec;17(3):261-268. doi: 10.1016/j.ijchp.2017.07.003. Epub 2017 Aug 14.</citation>
    <PMID>30487901</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>November 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</investigator_affiliation>
    <investigator_full_name>Cristina Trilla</investigator_full_name>
    <investigator_title>Principal investigador</investigator_title>
  </responsible_party>
  <keyword>Preeclampsia screening</keyword>
  <keyword>First-trimester</keyword>
  <keyword>Women's perception</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Stress</keyword>
  <keyword>Clinical practice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

